This guidance summarises the evidence for the effectiveness of post-exposure prophylaxis (PEP) for measles and provides advice on the assessment for PEP for high risk groups, in the following order of priority: immunosuppressed individuals pregnant women and infants
This guidance provides additional information for microbiologists regarding susceptibility testing for Shigella spp. It relates to PHE’s investigation of a specific MDR cluster of CTX-M-27 S. sonnei identified in the UK and USA in 2018 (10-SNP cluster CC 152 184.108.40.2060.1360.%). It also discusses the limited treatment
Detailed update on known HCID events around the world for November 2018. HCIDs are characterised by acute infectious illness, ability to spread person-to-person, high case-fatality rate, difficulty in rapid recognition and detection, lack of effective treatments and the need for co-ordination at the national
The Public Health England (PHE) emerging infections and zoonoses section uses an integrated horizon scanning approach which combines information on both human and animal health, to identify and assess outbreaks and incidents of new and emerging infectious diseases, reported nationally
This factsheet will help health professionals to identify and test cases of pertussis by providing: identification of cases treatment of cases laboratory testing for pertussis
This paper summarises the multi-step processes used in the Human Animal Infections and Risk Surveillance (HAIRS) group’s assessment of new and emerging threats of potential significance to the health of the UK public.
Quartlerly report with commentary, on cases confirmed by PHE’s Virus Reference Department or national routine laboratory testing (mumps only).
Algorithm on public health investigation and management of possible cases of MERS-CoV (Middle East respiratory syndrome coronavirus). The incubation period for Middle East respiratory syndrome coronavirus (MERS-CoV) is currently considered to be up to 14 days. Any respiratory illness occurring in
Monthly update on new or emerging infectious disease events that could affect UK public health.
The blood-borne virus (BBV) opt-out engagement event was led by Public Health England (PHE) working in partnership with NHS England and HMPPS to promote the final implementation stage of BBV opt-out testing for consenting eligible adults in prisons in England. The main
This report details high consequence infectious disease (HCID) events that are detected during PHE’s epidemic intelligence activities.
Latest available national data: on notifications of scarlet fever disease in England from invasive Group A Streptococci (iGAS) disease surveillance
Paper that identifies via discussion with public health and police workforces, the following topics as core areas of priority work and collaboration: violence prevention drugs and alcohol mental health dementia health and wellbeing hot and cold weather risk emerging infectious diseases modern
Briefing to provide an overview of the public health challenges and opportunities in relation to non-communicable diseases (NCDs) post Brexit. This briefing reviewed EU laws, regulations and policies to determine their impact on health, covering areas such as environmental and consumer
The most recent national estimates suggest that around 214,000 individuals are chronically infected with hepatitis C virus (HCV) in the UK; 160,000 of these are in England. Additional Items
This resource makes many useful recommendations on how TB Control Boards and their partners can better meet the needs of the under-served with TB, illustrated with numerous exemplars of good practice from across England. It defines the following as under-served: